Meeting
2019 ASCO Annual Meeting
Retrospective review for outcomes of IDH mutant, 1p/19q co-deleted gliomas based on initial treatment.
Authors
Christopher Ray Trevino
MD Anderson Cancer Center, Houston, TX
Christopher Ray Trevino , Shiao-Pei S. Weathers , Kristin Alfaro-Munoz , Gemma Hallatt , Garret L. Wiliford , Minjeong Park , Diane D. Liu , Tim Overeen , Jacob Joseph Mandel , John Frederick De Groot
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Central Nervous System Tumors
Track
Central Nervous System Tumors
Sub Track
Central Nervous System Tumors
Citation
J Clin Oncol 37, 2019 (suppl; abstr 2063)
DOI
10.1200/JCO.2019.37.15_suppl.2063
Abstract #
2063
Poster Bd #
252
Abstract Disclosures
Similar Posters
Poster
2014 ASCO Annual Meeting
PC or PCV? That is the question: A retrospective review of primary anaplastic oligodendroglial tumors treated with procarbazine and CCNU without or with vincristine.
First Author: Courtney C. Webre
Poster
2013 ASCO Annual Meeting
Rapid online feedback to improve clinical trial accrual: CODEL anaplastic glioma (AG) (NCCTG/Alliance N0577) as a model.
First Author: Holly Massett
First Author: Carlos Kamiya-Matsuoka
Poster
2014 ASCO Annual Meeting
Joint modeling of longitudinal health-related quality of life (HRQoL) data and survival.
First Author: Divine Ewane Ediebah